Coca Necsoi

2.2k total citations
23 papers, 146 citations indexed

About

Coca Necsoi is a scholar working on Infectious Diseases, Virology and Emergency Medicine. According to data from OpenAlex, Coca Necsoi has authored 23 papers receiving a total of 146 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Infectious Diseases, 11 papers in Virology and 7 papers in Emergency Medicine. Recurrent topics in Coca Necsoi's work include HIV Research and Treatment (11 papers), HIV/AIDS drug development and treatment (11 papers) and HIV/AIDS Research and Interventions (10 papers). Coca Necsoi is often cited by papers focused on HIV Research and Treatment (11 papers), HIV/AIDS drug development and treatment (11 papers) and HIV/AIDS Research and Interventions (10 papers). Coca Necsoi collaborates with scholars based in Belgium, Netherlands and United States. Coca Necsoi's co-authors include Nathan Clumeck, Marc Delforge, Stéphane De Wit, Stéphane De Wit, Coral García, Déborah Konopnicki, John S. Lambert, David M. Burger, Carmen Hidalgo Tenorio and Kabamba Kabeya and has published in prestigious journals such as Nature Communications, Clinical Infectious Diseases and Frontiers in Immunology.

In The Last Decade

Coca Necsoi

22 papers receiving 144 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Coca Necsoi Belgium	8	97	77	53	40	17	23	146
Rosie Mngqibisa South Africa	8	84 0.9×	30 0.4×	43 0.8×	50 1.3×	17 1.0×	19	134
Valentine Sing’oei Kenya	5	73 0.8×	33 0.4×	50 0.9×	31 0.8×	36 2.1×	19	143
Laura Comi Italy	9	127 1.3×	91 1.2×	32 0.6×	39 1.0×	5 0.3×	29	180
Win Min Han Thailand	9	132 1.4×	96 1.2×	90 1.7×	76 1.9×	6 0.4×	31	240
Berend J. van Welzen Netherlands	9	136 1.4×	98 1.3×	75 1.4×	78 1.9×	7 0.4×	26	216
Sharlaa Badal‐Faesen United States	9	161 1.7×	109 1.4×	71 1.3×	39 1.0×	14 0.8×	16	232
Margherita Bracchi United Kingdom	7	187 1.9×	126 1.6×	75 1.4×	98 2.5×	13 0.8×	25	268
Samuel Ferret France	6	109 1.1×	104 1.4×	51 1.0×	40 1.0×	13 0.8×	7	181
J Lange Netherlands	9	193 2.0×	147 1.9×	56 1.1×	55 1.4×	10 0.6×	17	248
Camilla Muccini Italy	9	164 1.7×	118 1.5×	42 0.8×	71 1.8×	6 0.4×	47	239

Countries citing papers authored by Coca Necsoi

Since Specialization

Citations

This map shows the geographic impact of Coca Necsoi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Coca Necsoi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Coca Necsoi more than expected).

Fields of papers citing papers by Coca Necsoi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Coca Necsoi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Coca Necsoi. The network helps show where Coca Necsoi may publish in the future.

Co-authorship network of co-authors of Coca Necsoi

This figure shows the co-authorship network connecting the top 25 collaborators of Coca Necsoi. A scholar is included among the top collaborators of Coca Necsoi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Coca Necsoi. Coca Necsoi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Dorman, Alexandra, Paolo Maiuri, Monika Bociąga‐Jasik, et al.. (2025). Nuclear retention of unspliced HIV-1 RNA as a reversible post-transcriptional block in latency. Nature Communications. 16(1). 2078–2078. 1 indexed citations

Touré, Yeya T., Charlotte Martin, Coca Necsoi, et al.. (2025). Experience of maternal immunization among women living with HIV in Belgium: A mixed-methods study. Preventive Medicine Reports. 54. 103107–103107.

Chen, Heng‐Chang, Paolo Maiuri, Simona Selberg, et al.. (2025). Inhibition of ALKBH5 demethylase of m6A pathway potentiates HIV-1 reactivation from latency. Virology Journal. 22(1). 124–124. 1 indexed citations

Konopnicki, Déborah, Christine Gilles, Yannick Manigart, et al.. (2025). Immunogenicity and Safety of 2 Versus 3 Doses of 9-Valent Vaccine Against Human Papillomavirus in Women With Human Immunodeficiency Virus: The Papillon Randomized Trial. Clinical Infectious Diseases. 1 indexed citations

Scheerder, Marie‐Angélique De, Virginie Mortier, Chris Verhofstede, et al.. (2024). Longitudinal patterns of inflammatory mediators after acute HIV infection correlate to intact and total reservoir. Frontiers in Immunology. 14. 1337316–1337316. 9 indexed citations

Deblonde, Jessika, Coca Necsoi, Jens Van Praet, et al.. (2024). Profile of Persons Recently Infected with HIV-1 in Belgium: New Insights to Tailor Prevention Efforts. AIDS and Behavior. 28(12). 4167–4178. 1 indexed citations

Willems, Fabienne, Charlotte Martin, Déborah Konopnicki, et al.. (2024). HIV-related immune activation attenuates polyfunctional IgG and memory B-cell responses to Tdap immunization during pregnancy. EBioMedicine. 104. 105179–105179. 2 indexed citations

Willems, Fabienne, Charlotte Martin, Coca Necsoi, et al.. (2023). Impact of pregnancy on polyfunctional IgG and memory B cell responses to Tdap immunization. Vaccine. 41(27). 4009–4018. 3 indexed citations

Necsoi, Coca, Carmen Hidalgo Tenorio, Coral García, et al.. (2021). Tenofovir Alafenamide Plasma Concentrations Are Reduced in Pregnant Women Living With Human Immunodeficiency Virus (HIV): Data From the PANNA Network. Clinical Infectious Diseases. 75(4). 623–629. 7 indexed citations

10.

Reschner, Anca, Coca Necsoi, Carole Nagant, et al.. (2021). Tetanus seroprotection in people living with HIV: Risk factors for seronegativity, evaluation of medical history and a rapid dipstick test. Vaccine. 39(14). 1963–1967. 2 indexed citations

11.

Necsoi, Coca, Carmen Hidalgo Tenorio, Coral García, et al.. (2020). Clinically Significant Lower Elvitegravir Exposure During the Third Trimester of Pregnant Patients Living With Human Immunodeficiency Virus: Data From the Pharmacokinetics of ANtiretroviral agents in HIV-infected pregNAnt women (PANNA) Network. Clinical Infectious Diseases. 71(10). e714–e717. 13 indexed citations

12.

Ghazi, Lama, Jason V. Baker, Shweta Sharma, et al.. (2019). Role of Inflammatory Biomarkers in the Prevalence and Incidence of Hypertension Among HIV-Positive Participants in the START Trial. American Journal of Hypertension. 33(1). 43–52. 7 indexed citations

13.

Kula, Anna, Nadège Delacourt, Sophie Bouchat, et al.. (2019). Heterogeneous HIV-1 Reactivation Patterns of Disulfiram and Combined Disulfiram+Romidepsin Treatments. JAIDS Journal of Acquired Immune Deficiency Syndromes. 80(5). 605–613. 17 indexed citations

14.

Clumeck, Nathan, et al.. (2014). First-line antiretroviral therapy with nevirapine versus lopinavir-ritonavir based regimens in a resource-limited setting. AIDS. 28(8). 1143–1153. 13 indexed citations

15.

Delforge, Marc, et al.. (2014). Cardiovascular risk evaluation of HIV‐positive patients in a case‐control study: comparison of the D:A:D and Framingham equations. Journal of the International AIDS Society. 17(4S3). 19515–19515. 12 indexed citations

16.

Clumeck, Nathan, Kabamba Kabeya, Vincent Cálvez, et al.. (2014). First-line therapy with LPV/r vs NVP and 2 NRTIs in a developing country: W144 of a randomized trial. BMC Infectious Diseases. 14(S2). 7 indexed citations

17.

Wit, Stéphane De, Marc Delforge, Coca Necsoi, & Nathan Clumeck. (2011). Down regulation of CD38 activation markers by atorvastatin in HIV patients with undetectable viral load. AIDS. 25(10). 1332–1333. 25 indexed citations

18.

Clumeck, Nathan, Kabamba Kabeya, Dolorès Vaira, et al.. (2011). The Lubumbashi Trial: Week 48 Data: Comparison between Lopinavir/r (LPV/r) versus Nevirapine (NVP)-based Regimens in Treatment-naïve Patients in a Developing Country. Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles). 4 indexed citations

19.

Wit, Stéphane De, Bénédicte Poll, Coca Necsoi, & Nathan Clumeck. (2006). Atazanavir has a better impact on lipid profiles than Fosamprenavir and Lopinavir in patients matched baseline triglycerides and cholesterol. Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles). 1 indexed citations

20.

Wit, Stéphane De, Bénédicte Poll, Coca Necsoi, & Nathan Clumeck. (2006). Fosamprenavir boosted with a single 100 mg capsule of Ritonavir as part of a once daily first line regimen in naive patients. Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles). 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact